UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Raised by Strategic Financial Concepts LLC

Strategic Financial Concepts LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 43,843.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 232,019 shares of the healthcare conglomerate’s stock after acquiring an additional 231,491 shares during the quarter. UnitedHealth Group makes up approximately 0.5% of Strategic Financial Concepts LLC’s portfolio, making the stock its 27th largest holding. Strategic Financial Concepts LLC’s holdings in UnitedHealth Group were worth $118,158,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of UNH. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. Delos Wealth Advisors LLC increased its position in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Signature Resources Capital Management LLC raised its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, August 30th. Barclays lifted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. UBS Group increased their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Finally, TD Cowen raised their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

Shares of NYSE UNH opened at $596.88 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $549.36 billion, a PE ratio of 36.48, a price-to-earnings-growth ratio of 1.68 and a beta of 0.58. The firm’s 50-day moving average is $558.98 and its 200-day moving average is $515.11. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.14 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.